Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose

Christoph, Patricia; Schuller, Christine; Studer, Hanna; Irion, Olivier; De Tejada, Begoña Martinez; Surbek, Daniel (2012). Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. Journal of perinatal medicine, 40(5), pp. 469-74. Berlin: Walter de Gruyter 10.1515/jpm-2011-0231

[img]
Preview
Text
jpm-2011-0231.pdf - Published Version
Available under License Publisher holds Copyright.

Download (153kB) | Preview
[img]
Preview
Text
jpm-2011-0231.pdf - Other
Available under License Publisher holds Copyright.

Download (131kB) | Preview

Oral iron substitution has shown to be insufficient for treatment of severe iron deficiency anemia in pregnancy. Ferric carboxymaltose is a new intravenous (i.v.) iron formulation promising to be more effective and as safe as iron sucrose. We aimed to assess side effects and tolerance of ferric carboxymaltose compared to i.v. iron sucrose in pregnant women.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology

UniBE Contributor:

Christoph, Patricia; Schuller, Regine-Christine and Surbek, Daniel

ISSN:

0300-5577

Publisher:

Walter de Gruyter

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:40

Last Modified:

24 Oct 2019 01:00

Publisher DOI:

10.1515/jpm-2011-0231

PubMed ID:

22945271

Web of Science ID:

000309408500001

BORIS DOI:

10.7892/boris.16475

URI:

https://boris.unibe.ch/id/eprint/16475 (FactScience: 224125)

Actions (login required)

Edit item Edit item
Provide Feedback